A wide range of evidence is now available to support the role of Sig-1R in the treatment of pain, mediating analgesia by Sig-1R antagonists [15], including models of neuropathic pain induced by partial nerve lesions [16], chronic constriction [14], diabetes [17] and chemotherapy administration [13]. The gene discussed is SIGMAR1; the disease is diabetes mellitus.